Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

NCT01319045 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01319045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2011
Completion date
May 31, 2013
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, eisenmenger's syndrome, pulmonary arterial hypertension